190A — Chordia Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Chordia Therapeutics, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.
2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -1,777 | 226 | -1,825 | -1,783 |
| Depreciation | ||||
| Non-Cash Items | -16.4 | -15.8 | -24.7 | -9.31 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 85.8 | 328 | -91.9 | -46.9 |
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -1,704 | 544 | -1,937 | -1,837 |
| Capital Expenditures | -13.5 | -0.723 | -0.537 | -5.33 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -1.15 | 1.07 | -10.4 | — |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -14.7 | 0.345 | -11 | -5.33 |
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 3,976 | 0 | 1,479 | 61.6 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 2,257 | 544 | -469 | -1,781 |